Tag: clinical-stage biopharmaceutical company
December 10, 2018
Millendo Therapeutics Announces Successful Merger Completion
Millendo Therapeutics, Inc. (Nasdaq:MLND), a clinical-stage biopharmaceutical company focused on developing novel treatments for orphan endocrine diseases, today announced that the...
July 29, 2018
5 Top Weekly NASDAQ Biotech Stocks: resTORbio Leads the Pack
resTORbio, ADMA Biologics, Misonix, Novus Therapeutics and Innovate Biopharmaceuticals were last week's top gainers on the NASDAQ Biotechnology Index.
July 4, 2018
5 Top NASDAQ Pharma Stocks of Q2 2018
About half way through 2018 finishing the second quarter, the INN takes a look at the 5 top pharma stocks...
July 3, 2018
4 Top Biotech Stocks on the TSX of Q2 2018
Which biotech stocks on the TSX have performed the best year-to-date? These four companies have risen to the top of...
May 23, 2018
Providing Non-Exclusive Licenses Makes Zymeworks “Lucky,” Says CEO
The Investing News Network spoke with Zymeworks CEO Ali Tehrani at the Bloom Burton & Co. Health Care Conference, which... May 10, 2018
Cellectar Granted Orphan Drug Designation for CLR 131 to Treat Rhabdomyosarcoma
Cellectar Biosciences (Nasdaq:CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of... May 9, 2018